|
Synonyms: antril | Kineret®
anakinra is an approved drug (FDA (no history prior to 2001), EMA (2002))
Compound class:
Peptide or derivative
Comment: This drug is a recombinant, nonglycosylated form of the endogenous IL-1 receptor antagonist peptide with an additional methionine at the amino terminus compared to the endogenous peptide.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖
View more information in the IUPHAR Pharmacology Education Project: anakinra |
Classification  |
|
| Compound class | Peptide or derivative |
| Approved drug? | Yes (FDA (no history prior to 2001), EMA (2002)) |
| International Nonproprietary Names |
|
| INN number | INN |
| 7137 | anakinra |
| Synonyms |
| antril | Kineret® |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 708 |
Reactome Drug
|
R-ALL-9681784 |
|
Reactome Reaction
|
R-HSA-9681763 |
| Other databases | |
| CAS Registry No. | 143090-92-0 |
| ChEMBL Ligand | CHEMBL1201570 |
| DrugBank Ligand | DB00026 |
| GtoPdb PubChem SID | 178103551 |
| Search PubMed clinical trials | anakinra |
| Search PubMed titles | anakinra |
| Search PubMed titles/abstracts | anakinra |
| Wikipedia | Anakinra |
